Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Long-Term Deferred Tax (2016 - 2020)

Cumberland Pharmaceuticals (CPIX) has disclosed Long-Term Deferred Tax for 11 consecutive years, with $21802.0 as the latest value for Q3 2020.

  • Quarterly Long-Term Deferred Tax fell 50.0% to $21802.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $21802.0 through Sep 2020, down 50.0% year-over-year, with the annual reading at $21802.0 for FY2019, 75.0% down from the prior year.
  • Long-Term Deferred Tax hit $21802.0 in Q3 2020 for Cumberland Pharmaceuticals, roughly flat from $21802.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $3.5 million in Q1 2017 to a low of $21802.0 in Q4 2019.
  • Historically, Long-Term Deferred Tax has averaged $523162.6 across 5 years, with a median of $65407.5 in 2017.
  • Biggest YoY gain for Long-Term Deferred Tax was 0.0% in 2018; the steepest drop was 97.53% in 2018.
  • Year by year, Long-Term Deferred Tax stood at $3.1 million in 2016, then crashed by 97.2% to $87210.0 in 2017, then changed by 0.0% to $87210.0 in 2018, then crashed by 75.0% to $21802.0 in 2019, then changed by 0.0% to $21802.0 in 2020.
  • Business Quant data shows Long-Term Deferred Tax for CPIX at $21802.0 in Q3 2020, $21802.0 in Q2 2020, and $21802.0 in Q1 2020.